首页 > 市场调查报告书 > 医疗设备

药物递输设备

市场调查报告书

商品编码

1747306

吸入胶囊市场：按产品类型、按应用、按病患小组、按性别、按分销管道、按地区

Inhalation Capsules Market, By Product Type, By Application, By Patient Group, By Gender, By Distribution Channel, By Geography

出版日期: 2025年05月29日 | 出版商:

Coherent Market Insights | 英文 135 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计 2025 年全球吸入胶囊市场规模为 9.801 亿美元，到 2032 年将达到 15.244 亿美元，2025 年至 2032 年的复合年增长率为 6.5%。

报告范围		报告详细信息
基准年	2024	2025年的市场规模	9.801亿美元
效能数据	2020-2024	预测期	2025-2032
预测期：2025-2032年复合年增长率：	6.50%	2032年价值预测	15.244亿美元

近年来，随着呼吸系统疾病的日益普及以及对便捷有效的药物输送系统的需求不断增长，全球吸入胶囊市场经历了显着增长。吸入胶囊是一种给药方式，将药物封装在小巧便携的胶囊中，并使用特定装置吸入。这种给药方式相较于传统的口服和注射方法具有多种优势，包括起效更快、靶向输送至肺部以及减少全身暴露。吸入胶囊市场应用广泛，从治疗气喘和慢性阻塞性肺病(COPD) 到管理过敏和其他呼吸系统疾病。随着医疗保健产业继续关注以患者为中心的解决方案和创新的药物输送技术，预计未来几年吸入胶囊市场将大幅成长。

市场动态：

市场的主要驱动因素之一是气喘和慢性阻塞性肺病 (COPD) 等呼吸系统疾病的日益流行，这些疾病需要有效且便捷的给药方式。此外，老年人口的成长（老年人易患呼吸系统疾病）也进一步推动了吸入胶囊的需求。此外，人们对标靶给药益处的认识不断提高，以及先进吸入设备的普及，也促进了市场的成长。然而，市场也存在一些限制因素，例如吸入胶囊的高昂研发和製造成本以及严格的核准监管要求。

此外，定量吸入器和雾化器等替代给药方式的出现也可能对市场成长构成挑战。儘管有这些限制因素，但随着新兴经济体对个人化医疗、新型製剂开发和医疗基础建设的日益重视，吸入胶囊市场仍蕴藏着巨大的成长机会。随着製药公司持续投资研发活动并与设备製造商合作，预计未来几年市场将迎来创新产品的发布和策略合作伙伴关係的建立。

本研究的主要特点

本报告对全球吸入胶囊市场进行了详细分析，并以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模和年复合成长率（CAGR%）。
它揭示了各个领域的潜在商机，并解释了该市场有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的主要考察。
全球吸入胶囊市场的主要企业根据公司亮点、产品系列、关键亮点、财务绩效和策略等参数进行分析。
本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
全球吸入胶囊市场报告针对该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
相关人员可以透过用于分析全球吸入胶囊市场的各种策略矩阵来促进他们的决策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 980.1 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	6.50%	2032 Value Projection:	USD 1,524.4 Mn

The global inhalation capsules market has witnessed significant growth in recent years, driven by the increasing prevalence of respiratory disorders and the rising demand for convenient and effective drug delivery systems. Inhalation capsules are a type of pharmaceutical dosage form that encapsulates medication in a small, portable capsule, which is then inhaled using a specific device. This method of drug administration offers several advantages over traditional oral or injectable routes, including rapid onset of action, targeted delivery to the lungs, and reduced systemic exposure. The market for inhalation capsules encompasses a wide range of applications, from the treatment of asthma and chronic obstructive pulmonary disease (COPD) to the management of allergies and other respiratory conditions. As the healthcare industry continues to focus on patient-centric solutions and innovative drug delivery technologies, the inhalation capsules market is poised for substantial growth in the coming years.

Market Dynamics:

One of the primary drivers of the market is the increasing prevalence of respiratory disorders, such as asthma and COPD, which require effective and convenient drug delivery methods. Additionally, the growing geriatric population, who are more susceptible to respiratory ailments, further fuels the demand for inhalation capsules. Moreover, the rising awareness about the benefits of targeted drug delivery and the availability of advanced inhalation devices contribute to the market's growth. However, the market also faces certain restraints, such as the high cost of development and manufacturing of inhalation capsules, as well as the strict regulatory requirements for approval.

Furthermore, the availability of alternative drug delivery methods, such as metered-dose inhalers and nebulizers, may pose a challenge to the market's growth. Despite these restraints, the inhalation capsules market presents significant opportunities for growth, driven by the increasing focus on personalized medicine, the development of novel drug formulations, and the expansion of healthcare infrastructure in emerging economies. As pharmaceutical companies continue to invest in research and development activities and collaborate with device manufacturers, the market is expected to witness innovative product launches and strategic partnerships in the coming years.

Key features of the study:

This report provides in-depth analysis of the global inhalation capsules market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global inhalation capsules market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Novartis, Pfizer, Teva Pharmaceutical Industries, Merck & Co., Mylan N.V., Sun Pharmaceutical Industries, Hikma Pharmaceuticals, Otsuka Pharmaceutical, Chiesi Farmaceutici, Cipla, AbbVie, and Sanofi
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global inhalation capsules market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global inhalation capsules market

Market Segmentation

Product Type Insights (Revenue, USD Mn, 2020 - 2032)
- Dry Powder Inhaler
- Soft Mist Inhalers
- Nebulizer Capsules
- Pressurized Metered-Dose Inhalers
- Others (Unit-dose vials, disposable nebulizers)
Application Insights (Revenue, USD Mn, 2020 - 2032)
- Asthma
- Chronic Obstructive Pulmonary Disease (COPD)
- Bronchitis
- Pulmonary Fibrosis
- Cystic Fibrosis
- Other Respiratory Disorders
Patient Group Insights (Revenue, USD Mn, 2020 - 2032)
- Adults
- Paediatric
- Geriatric
Gender Insights (Revenue, USD Mn, 2020 - 2032)
- Male
- Female
Distribution Channel Insights (Revenue, USD Mn, 2020 - 2032)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Regional Insights (Revenue, USD Mn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- GlaxoSmithKline
- AstraZeneca
- Boehringer Ingelheim
- Novartis
- Pfizer
- Teva Pharmaceutical Industries
- Merck & Co.
- Mylan N.V.
- Sun Pharmaceutical Industries
- Hikma Pharmaceuticals
- Otsuka Pharmaceutical
- Chiesi Farmaceutici
- Cipla
- AbbVie
- Sanofi

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Inhalation Capsules Market, By Product Type
- Global Inhalation Capsules Market, By Application
- Global Inhalation Capsules Market, By Patient Group
- Global Inhalation Capsules Market, By Gender
- Global Inhalation Capsules Market, By Distribution Channel
- Global Inhalation Capsules Market, By Region

3. Market Dynamics, Regulations, And Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Inhalation Capsules Market, By Product Type, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Dry Powder Inhaler
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Soft Mist Inhalers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Nebulizer Capsules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Pressurized Metered-Dose Inhalers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Others (Unit-dose vials, disposable nebulizers)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

5. Global Inhalation Capsules Market, By Application, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Asthma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Chronic Obstructive Pulmonary Disease (COPD)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Bronchitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Pulmonary Fibrosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Cystic Fibrosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Other Respiratory Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Inhalation Capsules Market, By Patient Group, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Adults
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Paediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Inhalation Capsules Market, By Gender, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Male
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Female
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Inhalation Capsules Market, By Distribution Channel, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

9. Global Inhalation Capsules Market, By Region, 2020 - 2032, Value (USD Mn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Patient Group, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Patient Group, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Patient Group, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Patient Group, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Patient Group, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Patient Group, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
South Africa
North Africa
Central Africa

10. Competitive Landscape

GlaxoSmithKline
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AstraZeneca
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Boehringer Ingelheim
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Novartis
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Pfizer
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Teva Pharmaceutical Industries
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck & Co.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Mylan N.V.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sun Pharmaceutical Industries
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Hikma Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Otsuka Pharmaceutical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Chiesi Farmaceutici
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Cipla
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AbbVie
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sanofi
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies

11. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

12. References and Research Methodology

References
Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

吸入胶囊市场：按产品类型、按应用、按病患小组、按性别、按分销管道、按地区